A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia
- PMID: 22389068
- PMCID: PMC3388505
- DOI: 10.1002/ajh.23138
A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia
Abstract
Essential thrombocythemia (ET) is a rare type of myeloproliferative neoplasm characterized by clonal expansion of the megakaryocyte and platelet lineage. Here, we describe a novel mutation (Y252H) in the thrombopoietin (TPO) receptor, or MPL, in a JAK2 mutation-negative ET patient. The bone marrow examination revealed increased numbers of dysmorphic megakaryocytes with focal clustering. The x-inactivation pattern suggested clonal expansion of hematopoietic cells in the bone marrow. Furthermore, we found that the patient's bone marrow cells were hypersensitive to TPO in generating megakaryocyte colonies in vitro. More importantly, we demonstrated that this MPL Y252H mutant confers increased TPO/MPL-mediated cell growth and increased cell survival upon cytokine withdrawal in BaF3 cells, indicating it is a disease-driving mutation and may contribute to the development of ET in vivo. In summary, this is the first report describing a mutation in the extracellular domain of MPL underlying ET.
Conflict of interest statement
The authors have no relevant conflict of interest.
Figures

Similar articles
-
Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.Leukemia. 2008 Aug;22(8):1551-6. doi: 10.1038/leu.2008.115. Epub 2008 May 22. Leukemia. 2008. PMID: 18496561
-
MPL W515L mutation in pediatric essential thrombocythemia.Pediatr Blood Cancer. 2013 Aug;60(8):E52-4. doi: 10.1002/pbc.24500. Epub 2013 Feb 25. Pediatr Blood Cancer. 2013. PMID: 23441089
-
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.J Clin Pathol. 2018 Nov;71(11):975-980. doi: 10.1136/jclinpath-2018-205227. Epub 2018 Jun 22. J Clin Pathol. 2018. PMID: 29934356
-
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7. Acta Haematol. 2015. PMID: 25116092 Review.
-
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.Blood. 2017 Feb 9;129(6):680-692. doi: 10.1182/blood-2016-10-695957. Epub 2016 Dec 27. Blood. 2017. PMID: 28028026 Free PMC article. Review.
Cited by
-
Primary thrombocytosis in children.Haematologica. 2014 Apr;99(4):620-8. doi: 10.3324/haematol.2013.092684. Haematologica. 2014. PMID: 24688110 Free PMC article. Review.
-
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.Ann Hematol. 2021 Jul;100(7):1647-1665. doi: 10.1007/s00277-021-04485-0. Epub 2021 Mar 12. Ann Hematol. 2021. PMID: 33712866 Free PMC article. Review.
-
MPL Y252H anMd PL F126fs mutations in essential thrombocythemia: Case series and review of literature.Hematol Rep. 2019 Mar 12;11(1):7868. doi: 10.4081/hr.2019.7868. eCollection 2019 Feb 19. Hematol Rep. 2019. PMID: 30996850 Free PMC article.
-
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.Blood. 2016 Jan 21;127(3):325-32. doi: 10.1182/blood-2015-07-661835. Epub 2015 Sep 30. Blood. 2016. PMID: 26423830 Free PMC article.
-
Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran.Iran J Pathol. 2018 Fall;13(4):397-402. Epub 2018 Sep 25. Iran J Pathol. 2018. PMID: 30774677 Free PMC article.
References
-
- Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22:14–22. - PubMed
-
- Drachman JG, Kaushansky K. Structure and function of the cytokine receptor superfamily. Curr Opin Hematol. 1995;2:22–28. - PubMed
-
- Watowich SS, Wu H, Socolovsky M, Klingmuller U, Constantinescu SN, Lodish HF. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol. 1996;12:91–128. - PubMed
-
- Beer PA. The pathogenesis of essential thrombocythemia. Curr Opin Hematol. 2011;18:323–329. - PubMed
-
- Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006;3:e270. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous